Clinical Trial Update: An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating tilmanocept via IV injection with SPECT/CT versus PET imaging in subjects with liver metastases; study terminated with posted results i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma
• Liver Metastases

Drugs mentioned

• Tilmanocept (Tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Liver Metastases, Colorectal Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2019-11-18